metastatic prostate cancer

You have access
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with ¹⁸F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
You have access
¹⁷⁷Lutetium PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castrate-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial
Sarennya Pathmanandavel, Megan Crumbaker, Andrew O. Yam, Andrew Nguyen, Christopher Rofe, Elizabeth Hovey, Craig Gedye, Edmond M. Kwan, Christine Hauser, Arun A. Azad, Peter Eu, Andrew J. Martin, Anthony M. Joshua and Louise Emmett

Journal of Nuclear Medicine July 29, 2021, jnumed.121.262552; DOI: https://doi.org/10.2967/jnumed.121.262552
You have access
A Prospective Comparison of ¹⁸F-Sodium Fluoride PET/CT and PSMA-Targeted ¹⁸F-DCFBC PET/CT in Metastatic Prostate Cancer
Stephanie A. Harmon, Ethan Bergvall, Esther Mena, Joanna H. Shih, Stephen Adler, Yolanda McKinney, Sherif Mehralivand, Deborah E. Citrin, Anna Couvillon, Ravi A. Madan, James L. Gulley, Ronnie C. Mease, Paula M. Jacobs, Martin G. Pomper, Baris Turkbey, Peter L. Choyke and M. Liza Lindenberg

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1665-1671; DOI: https://doi.org/10.2967/jnumed.117.207373
You have access
A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition
Aseem Anand, Michael J. Morris, Reza Kaboteh, Mariana Reza, Elin Trägårdh, Naofumi Matsunaga, Lars Edenbrandt, Anders Bjartell, Steven M. Larson and David Minarik

Journal of Nuclear Medicine December 1, 2016, 57 (12) 1865-1871; DOI: https://doi.org/10.2967/jnumed.116.177030
You have access
Repeatability of Quantitative ¹⁸F-NaF PET: A Multicenter Study
Christie Lin, Tyler Bradshaw, Timothy Perk, Stephanie Harmon, Jens Eickhoff, Ngoneh Jallow, Peter L. Choyke, William L. Dahut, Steven Larson, John Laurence Humm, Scott Perlman, Andrea B. Apolo, Michael J. Morris, Glenn Liu and Robert Jeraj

Journal of Nuclear Medicine December 1, 2016, 57 (12) 1872-1879; DOI: https://doi.org/10.2967/jnumed.116.177295
You have access
Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
Aseem Anand, Michael J. Morris, Reza Kaboteh, Lena Båth, May Sadik, Peter Gjertsson, Milan Lomsky, Lars Edenbrandt, David Minarik and Anders Bjartell

Journal of Nuclear Medicine January 1, 2016, 57 (1) 41-45; DOI: https://doi.org/10.2967/jnumed.115.160085
You have access
Comparison of Prostate-Specific Membrane Antigen–Based ¹⁸F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer
Steven P. Rowe, Katarzyna J. Macura, Anthony Ciarallo, Esther Mena, Amanda Blackford, Rosa Nadal, Emmanuel S. Antonarakis, Mario A. Eisenberger, Michael A. Carducci, Ashley E. Ross, Philip W. Kantoff, Daniel P. Holt, Robert F. Dannals, Ronnie C. Mease, Martin G. Pomper and Steve Y. Cho

Journal of Nuclear Medicine January 1, 2016, 57 (1) 46-53; DOI: https://doi.org/10.2967/jnumed.115.163782

Main menu

User menu

Search

metastatic prostate cancer